A Randomized Trial of Rectal Indomethacin and Papillary Spray of Epinephrine Versus Rectal Indomethacin to Prevent Post-ERCP Pancreatitis in High Risk Patients

Condition:   Post-ERCP Acute Pancreatitis
Interventions:   Drug: Rectal Indomethacin;   Drug: Epinephrine
Sponsors:   Johns Hopkins University;   American Society for Gastrointestinal Endoscopy;   Asian Institute of Gastroenterology, India;   Postgraduate Institute of Medical Education and Research;   Apollo Gleneagles Hospitals, India
Not yet recruiting – verified April 2014

View full post on ClinicalTrials.gov: asthma | received in the last 14 days

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.